Beacon Capital Management »

Lineage Cell Therapeutics In shares owned by Beacon Capital Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Beacon Capital Management from 13F filings

Historical chart of Beacon Capital Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Beacon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Beacon Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.5k 15k 0.50
2024-09-30 $14k 15k 0.91
2024-06-30 $15k 15k 1.00
2024-03-31 $22k 15k 1.48
2023-12-31 $18k 15k 1.18

More positions owned by Beacon Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr Ultra Short Govt (BILZ)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Growth Etf (VUG)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard World Inf Tech Etf (VGT)
Apple (AAPL)
Simplify Exchange Traded Fun Managed Futures (CTA)
NVIDIA Corporation (NVDA)
Simplify Exchange Traded Fun Treasury Opt Inc (BUCK)
Simplify Exchange Traded Fun Volatility Prem (SVOL)

View all positions for Beacon Capital Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Group
Perceptive Advisors
Defender Capital
Raffles Associates
Alyeska Investment Group
Geode Capital Management
State Street Corporation
DAFNA Capital Management
Renaissance Technologies
Northern Trust
Jacobs Levy Equity Management
Jpmorgan Chase & Co
Brian McDonald

View all funds holding Lineage Cell Therapeutics In